Skip to main content
All tenders

Delivery of Antineoplastic Drugs for the Wielkopolskie Centrum Onkologii

Status
Active
Submission Deadline
6 days remaining
Location
Poznań, Poland
Procedure
Open Procedure · Supplies
Category
Antineoplastic agents.
Published
Reference
ted-595890-2026

Delivery of antineoplastic drugs: oral and intravenous medications reimbursed under drug programs and from the chemotherapy catalog.

Free

Never miss a tender again

We send you 3 current matches that fit your company.

We call you once briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email and calls you once about it. Revocable at any time. Privacy policy


Tender documents

  • Portal — LOT-0001NON-RESTRICTED-DOCUMENT
  • TED HTML — 595890-2026HTML
  • TED PDF — 595890-2026PDF
  • TED XML — 595890-2026XML
Free

Unlock documents for free

Enter your email address. If you confirm, we will also send you 3 similar tenders.

We call you once briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email and calls you once about it. Revocable at any time. Privacy policy


Lots (6)

  • LOT-0001Lieferung von antineoplastischen Medikamenten, Paket 1
  • LOT-0002Lieferung von antineoplastischen Medikamenten, Paket 2
  • LOT-0003Lieferung von antineoplastischen Medikamenten, Paket 3
  • LOT-0004Lieferung von antineoplastischen Medikamenten, Paket 4
  • LOT-0005Lieferung von antineoplastischen Medikamenten, Paket 5
  • LOT-0006Lieferung von antineoplastischen Medikamenten, Paket 6

Additional details

EU Funded
Yes
Electronic Submission
Required
Legal Basis
32014L0024
Live webinar

See Patterno work on a real tender

45 minutes live, questions answered in the chat. Upcoming dates on the signup page.

  • Matches from 4,500+ portals in one workspace
  • Qualify any tender against your criteria in minutes
  • Prepare bid documents from your company context

Prefer a private session?